Common Stock, Shares, Outstanding of GYRE THERAPEUTICS, INC. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
GYRE THERAPEUTICS, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • GYRE THERAPEUTICS, INC. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 91,314,007, a 5.8% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

GYRE THERAPEUTICS, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 91,314,007 +5,006,463 +5.8% 31 Dec 2025 10-K 13 Mar 2026 2025 FY
Q3 2025 90,890,381 +5,120,855 +6% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 90,822,828 +5,285,054 +6.2% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 87,636,209 +2,212,963 +2.6% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 86,307,544 +9,711,928 +13% 31 Dec 2024 10-K 13 Mar 2026 2025 FY
Q3 2024 85,769,526 +47,791,384 +126% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 85,537,774 +47,562,882 +125% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 85,423,246 +47,663,421 +126% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 76,595,616 +13,007,497 +20% 31 Dec 2023 10-K 17 Mar 2025 2024 FY
Q3 2023 37,978,142 +6,488,089 +21% 30 Sep 2023 10-Q 26 Oct 2023 2023 Q3
Q2 2023 37,974,892 +6,497,839 +21% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 37,759,825 +6,282,772 +20% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 63,588,119 +32,178,412 +102% 31 Dec 2022 10-K 27 Mar 2024 2023 FY
Q3 2022 31,490,053 +9,392,233 +43% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 31,477,053 +127,313 +0.41% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 31,477,053 +146,026 +0.47% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 31,409,707 +9,311,887 +42% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 22,097,820 +14,896 +0.07% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 31,349,740 +9,298,995 +42% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 31,331,027 +13,911,714 +80% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 22,097,820 +10,056,985 +84% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 22,082,924 +10,052,932 +84% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 22,050,745 +10,042,217 +84% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 17,419,313 +5,445,209 +45% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 12,040,835 +86,307 +0.72% 31 Dec 2019 10-K 04 Mar 2021 2020 FY
Q3 2019 12,029,992 +87,263 +0.73% 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 12,008,528 +65,799 +0.55% 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 11,974,104 +39,023 +0.33% 31 Mar 2019 10-Q 02 May 2019 2019 Q1
Q4 2018 11,954,528 +5,873,298 +97% 31 Dec 2018 10-K 20 Feb 2020 2019 FY
Q3 2018 11,942,729 +7,632,168 +177% 30 Sep 2018 10-Q 01 Nov 2018 2018 Q3
Q2 2018 11,942,729 +7,632,168 +177% 30 Jun 2018 10-Q 02 Aug 2018 2018 Q2
Q1 2018 11,935,081 +10,935,045 +1093% 31 Mar 2018 10-Q 03 May 2018 2018 Q1
Q4 2017 6,081,230 +5,279,474 +658% 31 Dec 2017 10-K 08 Mar 2019 2018 FY
Q3 2017 4,310,561 -7,625,420 -64% 30 Sep 2017 10-Q 02 Nov 2017 2017 Q3
Q2 2017 4,310,561 -7,193,053 -63% 30 Jun 2017 10-Q 03 Aug 2017 2017 Q2
Q1 2017 1,000,036 -10,430,072 -91% 31 Mar 2017 10-Q 11 May 2017 2017 Q1
Q4 2016 801,756 +39,751 +5.2% 31 Dec 2016 10-K 19 Mar 2018 2017 FY
Q3 2016 11,935,981 +524,301 +4.6% 30 Sep 2016 10-Q 03 Nov 2016 2016 Q3
Q2 2016 11,503,614 +1,693,042 +17% 30 Jun 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 11,430,108 -22,442,206 -66% 31 Mar 2016 10-Q 05 May 2016 2016 Q1
Q4 2015 762,005 +391,061 +105% 31 Dec 2015 10-K 08 Mar 2017 2016 FY
Q3 2015 11,411,680 -22,382,055 -66% 30 Sep 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 9,810,572 -23,983,163 -71% 30 Jun 2015 8-K/A 23 Oct 2015
Q1 2015 33,872,314 +87,725 +0.26% 31 Mar 2015 10-Q 07 May 2015 2015 Q1
Q4 2014 370,944 -9,189,628 -96% 31 Dec 2014 10-K 09 Mar 2016 2015 FY
Q3 2014 33,793,735 +135,324 +0.4% 30 Sep 2014 10-Q 06 Nov 2014 2014 Q3
Q2 2014 33,793,735 +156,724 +0.47% 30 Jun 2014 10-Q 07 Aug 2014 2014 Q2
Q1 2014 33,784,589 +167,914 +0.5% 31 Mar 2014 10-Q 08 May 2014 2014 Q1
Q4 2013 9,560,572 -24,054,509 -72% 31 Dec 2013 8-K/A 23 Oct 2015
Q3 2013 33,658,411 +52,126 +0.16% 30 Sep 2013 10-Q 06 Nov 2013 2013 Q3
Q2 2013 33,637,011 +208,375 +0.62% 30 Jun 2013 10-Q 07 Aug 2013 2013 Q2
Q1 2013 33,616,675 +218,882 +0.66% 31 Mar 2013 10-Q 08 May 2013 2013 Q1
Q4 2012 33,615,081 +231,678 +0.69% 31 Dec 2012 10-K 14 Mar 2014 2013 FY
Q3 2012 33,606,285 +227,753 +0.68% 30 Sep 2012 10-Q 08 Nov 2012 2012 Q3
Q2 2012 33,428,636 +56,573 +0.17% 30 Jun 2012 10-Q 09 Aug 2012 2012 Q2
Q1 2012 33,397,793 31 Mar 2012 10-Q 09 May 2012 2012 Q1
Q4 2011 33,383,403 +4,512,712 +16% 31 Dec 2011 10-K 15 Mar 2013 2012 FY
Q3 2011 33,378,532 30 Sep 2011 10-Q 03 Nov 2011 2011 Q3
Q2 2011 33,372,063 30 Jun 2011 10-Q 09 Aug 2011 2011 Q2
Q4 2010 28,870,691 31 Dec 2010 10-K 06 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.